SSEA-4 Antibody MAB1435 from R&D Systems, a Bio-Techne Brand

Product Specs
ItemSSEA-4 Antibody
CompanyR&D Systems, a Bio-Techne Brand
Price Pricing Info Supplier Page View Company Product Page
Catalog NumberMAB1435
ApplicationsFlow Cytometry, Immunocytochemistry
CloneMC-813-70
IsotypeIgG3
Conjugate/TagUnconjugated
TargetSSEA-4
ReactivityHuman, Mouse
Quantity100 ug (also 25 ug)
HostMouse
ClonalityMonoclonal
FormatLyophilized from a 0.2 µm filtered solution in MES with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS
Immunogen2120Ep human embryonal carcinoma cell line
ConcentrationLYOPH
Brand/TrademarkR&D Systems, a Bio-Techne Brand
PurityProtein A or G purified from hybridoma culture supernatant
Antibody TypePrimary Antibodies
StorageUse a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 6 months, -20 to -70 °C under sterile conditions after reconstitution

Specifications/Features

Available conjugates: Unconjugated

Specificity: Recognizes a carbohydrate epitope of SSEA-4 (1, 2)

Add to Compare List

R&D Systems, a Bio-Techne Brand

614 McKinley Place N.E.

Minneapolis, Minnesota 55413

United States

Phone: 1 (800) 343-7475
1 (612) 379-2956

Fax: 1 (612) 656-4400

Company Profile

Website: http://www.rndsystems.com

(1) High expression of embryonic stem cell marker SSEA3 confers poor prognosis and promotes epithelial mesenchymal transition in hepatocellular carcinomaBiomedical JournalJune 7, 2023Tsai-Hsien Hung, Yenlin Huang, Chau-Ting Yeh, Chun-Nan Yeh, John Yu, Chun-Cheng Lin, Shih-Pin Chiou, Pei-Yun Chiang, Jung-Tung Hung, Alice L. Yu

(2) Transcriptomic analysis of feeder-free culture system for maintaining naïve-state pluripotency in human pluripotent stem cellsStem Cell InvestigationApril 19, 2023Wataru Isono, Tomoyuki Kawasaki, Justin K. Ichida, Kazunori Nagasaka, Osamu Hiraike, Akihiro Umezawa, Hidenori AkutsuSanta Cruz Biotechnology, Dallas, TX, USA), NANOG (ReproCell), Tra1-60 (MAB4360; Sigma-Aldrich), SSEA4 (MAB1435; R&D Systems), SSEA1 (MAB2155; R&D Systems), KLF4 (ab216875; Abcam), PRDM14 (ab187881; Abcam), anti-βIII

(3) Cell-type dependent regulation of pluripotency and chromatin remodeling genes by hydralazineStem Cell Research & TherapyMarch 16, 2023Alain Aguirre-Vázquez, Fabiola Castorena-Torres, Beatriz Silva-Ramírez, Katia Peñuelas-Urquides, María Elena Camacho-Moll, Luis A. Salazar-Olivo, Iván Velasco, Mario Bermúdez de León(R&D Systems, MAB2018, 1:100), rabbit anti-NANOG (Prepotech 500-P236, 1:1,000), mouse anti-SSEA4 (R&D Systems MAB1435, 1:100), rabbit anti-NRF2 (Abcam ab31163, 1:200) and HIF1A (Santa Cruz Biotechnology sc-13515, 1:25).

(4) Derivation of Limbal Stem Cells from Human Adult Mesenchymal Stem Cells for the Treatment of Limbal Stem Cell DeficiencyInternational journal of molecular sciencesJanuary 25, 2023Cadenas-Martin M, Arnalich-Montiel F, Miguel MP.

(5) Derivation of Sendai-Virus-Reprogrammed Human iPSCs-Neuronal Precursors: In Vitro and In Vivo Post-grafting Safety CharacterizationCell transplantationJanuary 1, 2023Shigyo M, Kobayashi Y, Platoshyn O, Marsala S, Kato T Jr, Takamura N, Yoshida K, Kishino A, Bravo-Hernandez M, Juhas S, et al.immunofluorescence staining,Primary antibodies used for immunofluorescence staining AF1759,OCT-3/4,R&D systems MAB1435,SSEA4,R&D systems AB5603,SOX2,Millipore Sigma AF1997,Nanog,R&D systems MAB6326,Nestin,Millipore Sigma 610920,N-cadherin,BD Biosciences

(6) Establishment of a human induced pluripotent stem cell line (TAUi008-A) derived from a multiple sclerosis patientStem cell researchAugust 1, 2022Lotila J, Hyvärinen T, Skottman H, Airas L, Narkilahti S, Hagman S.

(7) Generation of iPSC line FAMRCi010-A from patient with restrictive cardiomyopathy carrying genetic variant FLNC p.Gly2011ArgStem cell researchMarch 1, 2022Perepelina K, Khudiakov A, Rodina N, Boytsov A, Vavilova T, Zlotina A, Sokolnikova P, Kostareva A.

(8) Generation of iPSC line (FAMRCi009-A) from patient with familial progressive cardiac conduction disorder carrying genetic variant FLNC p.Val2264MetStem cell researchMarch 1, 2022Rodina N, Khudiakov A, Perepelina K, Muravyev A, Boytsov A, Zlotina A, Sokolnikova P, Kostareva A.

(9) Alternative splicing is a developmental switch for hTERT expressionMolecular cellJune 3, 2021Penev A, Bazley A, Shen M, Boeke JD, Savage SA, Sfeir A.monoclonal GAPDH (0411),Santa Cruz Biotech.,sc-47724 Mouse monoclonal SSEA-4 (MC-813–70),R&D Systems,MAB1435 Mouse monoclonal COL1A1 (3G3),Santa Cruz Biotech.,sc-293182 Bacterial and virus strains,Bacterial

(10) Evaluation of the Age- and Sex-Related Changes of the Osteogenic Differentiation Potentials of Healthy Bone Marrow-Derived Mesenchymal Stem CellsMedicina (Kaunas)May 22, 2021Hyun-Jin Lee, Hyuna Lee, Chae-Bin Na, In-Seok Song, Jae-Jun Ryu, Jun-Beom ParkUSA). 2.3. Immunofluorescence An immunofluorescent assay was performed using human SSEA-4 antibody (mab1435, R&D Systems, Inc., Minneapolis, MN, USA) on Day 3. The BMSCs were fixated, permeabilized, blocked,

(11) Comparative evaluation of isogenic mesodermal and ectomesodermal chondrocytes from human iPSCs for cartilage regenerationScience advancesMay 1, 2021Lee MS, Stebbins MJ, Jiao H, Huang HC, Leiferman EM, Walczak BE, Palecek SP, Shusta EV, Li WJ.

(12) Grafted human induced pluripotent stem cells improve the outcome of spinal cord injury: modulation of the lesion microenvironmentScientific reportsDecember 29, 2020Bellák T, Fekécs Z, Török D, Táncos Z, Nemes C, Tézsla Z, Gál L, Polgári S, Kobolák J, Dinnyés A, et al.antibodies and lectin were used as follows: mouse anti-SSEA4 stage-specific embryonic antigen-4, 1:200, MAB1435, R&D Systems), mouse anti-SC-101 (human nuclear marker, 1:500, Y40400, Clontech Laboratories), mouse

(13) The combination of dibenzazepine and a DOT1L inhibitor enables a stable maintenance of human naïve-state pluripotency in non-hypoxic conditionsRegenerative therapyDecember 1, 2020Isono W, Kawasaki T, Ichida JK, Ayabe T, Hiraike O, Umezawa A, Akutsu H.Santa Cruz Biotechnology, Dallas, TX), NANOG (ReproCell), Tra 1-60 (MAB4360; Sigma–Aldrich), SSEA4 (MAB1435, R&D Systems), KLF4 (ab216875; Abcam), PRDM14 (ab187881; Abcam), anti-βIII Tubulin (TUJ1, Promega, Madison,

(14) Generation of two iPSC lines (FAMRCi007-A and FAMRCi007-B) from patient with Emery-Dreifuss muscular dystrophy and heart rhythm abnormalities carrying genetic variant LMNA p.Arg249GlnStem cell researchJune 29, 2020Perepelina K, Kostina A, Klauzen P, Khudiakov A, Rabino M, Crasto S, Zlotina A, Fomicheva Y, Sergushichev A, Oganesian M, et al.

(15) Generation of two induced pluripotent stem cell lines (FAMRCi005-A and FAMRCi005-B) from patient carrying genetic variant LMNA p.Asp357ValStem cell researchMarch 1, 2020Klauzen P, Perepelina K, Khudiakov A, Zlotina A, Fomicheva Y, Pervunina T, Vershinina T, Kostareva A, Malashicheva A.

(16) Generation of two iPSC lines (FAMRCi006-A and FAMRCi006-B) from patient with dilated cardiomyopathy and Emery-Dreifuss muscular dystrophy associated with genetic variant LMNAp.Arg527ProStem cell researchMarch 1, 2020Perepelina K, Klauzen P, Khudiakov A, Zlotina A, Fomicheva Y, Rudenko D, Gordeev M, Sergushichev A, Malashicheva A, Kostareva A.

(17) Generation of two iPSC lines (FAMRCi004-A and FAMRCi004-B) from patient with familial progressive cardiac conduction disorder carrying genetic variant DSP p.His1684ArgStem cell researchMarch 1, 2020Khudiakov A, Perepelina K, Klauzen P, Zlotina A, Gusev K, Kaznacheyeva E, Malashicheva A, Kostareva A.

(18) Protein corona formation moderates the release kinetics of ion channel antagonists from transferrin-functionalized polymeric nanoparticles†RSC AdvancesJanuary 14, 2020Priya S. R. Naidu, Eleanor Denham, Carole A. Bartlett, Terry McGonigle, Nicolas L. Taylor, Marck Norret, Nicole. M. Smith, Sarah A. Dunlop, K. Swaminathan Iyer, Melinda Fitzgeraldmicroglial activation markers Iba1 (1:500; Abcam, goat Ab5076) and ED1 (1:500; Merck Millipore, mouse MAB1435); oligodendroglial indicator oligodendrocyte transcription factor 2 (Olig2; 1:500; R&D Systems, goat

(19) Generation of Human‐Induced Pluripotent Stem Cells From Anterior Cruciate LigamentJournal of Orthopaedic ResearchJanuary 1, 2020Steven Woods, Nicola Bates, Sara L. Dunn, Ferdinand Serracino‐Inglott, Tim E. Hardingham, Susan J. KimberCell Signaling Technology), SSEA‐3 (1:200, cat. no MAB1434; R&D Systems, Abingdon, UK), SSEA‐4 (1:200, cat. no MAB1435; R&D Systems), TRA‐1‐60 (1:200, cat. no. Ab16288; Abcam, Cambridge, UK), TRA‐1‐81 (1:200, cat. no. Ab16289;

(20) Comparing modes of delivery of a combination of ion channel inhibitors for limiting secondary degeneration following partial optic nerve transectionScientific reportsOctober 25, 2019Toomey LM, Bartlett CA, Gavriel N, McGonigle T, Majimbi M, Gopalasingam G, Rodger J, Fitzgerald M.microglial activation markers Iba1 (1:500; Abcam, goat Ab5076) and ED1 (1:500; Merck Millipore, mouse MAB1435); oligodendroglial indicators oligodendrocyte transcription factor 2 (Olig2; 1:500; R&D Systems, goat

Be the First to Write a Review!

SSEA-4 Antibody

SSEA-4 Antibody

SSEA-4 Antibody

SSEA-4 Antibody from R&D Systems, a Bio-Techne Brand

Specifications/Features

R&D Systems, a Bio-Techne Brand

Citations (66)

Reviews

SSEA-4 Antibody from R&D Systems, a Bio-Techne Brand

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map